Background—Heparin-induced thrombocytopenia (HIT) is an immune-mediated syndrome
caused by heparin. Complications range from thrombocytopenia to thrombocytopenia with …

BACKGROUND AND PURPOSE: The cause of “posterior reversible encephalopathy syndrome”
(PRES) is not established. We recently encountered several patients who developed …

Thrombotic thrombocytopenic purpura (TTP) is a potentially fatal disease that is treated with
plasma exchange and typically with replacement with fresh frozen plasma (FFP). This …

Bone marrow transplant-associated thrombotic microangiopathy (BMT-TM) has been reported
with widely varying frequencies and outcomes. Therefore a BMT-TM grading system (0-4) …

BACKGROUND AND PURPOSE: Transplantation conditioning regimens have been shown
to affect the brain imaging appearance in patients with cyclosporine or FK-506 neurotoxicity. …

Endothelial damage is thought to be a contributing factor in the pathogenesis of Thrombotic
Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS). The present studies …

… Zeigler ZR: Platelet glass bead retention is useful in monitoring … Zeigler ZR: Nonocclusive
bleeding times may improve the value of Ivy bleeding times. Thromb Haemost 63:371, 1990. 16…

Patients with myelodysplastic syndromes (MDS) who were anemic and/or thrombocytopenic
were treated with 5-azacytidine (5-AZA) at a dose of 75mg/m 2 per day SQ×7 days. This …

: To evaluate the effects of mental stress on blood platelet activity, platelet secretion and
aggregation were measured in 40 healthy young men, assigned in a 3: 1 ratio to an …

Bone marrow transplant‐associated thrombotic microangiopathy (BMT‐TM) ranges in severity
from a self‐limited to a fatal disorder. There has been no specific therapy for this condition. …